Price target
110.880.00 0.00%
The 17 analysts offering 1 year price forecasts for 2L9 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 18 analysts giving stock ratings to 2L9 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
2L9 EPS for the last quarter is 1.34 EUR despite the estimation of −1.54 EUR. In the next quarter EPS is expected to reach −1.21 EUR. Track more of BLUEPRINT MEDICINES CORP financials and stay on top of what is up with the company.
In the next quarter BLUEPRINT MEDICINES CORP revenue is expected to reach 95.87 M EUR. Check out BLUEPRINT MEDICINES CORP revenue and earnings and make informed decisions.
According to analysts, 2L9 price target is 110.88 EUR with a max estimate of 156.00 EUR and a min estimate of 69.64 EUR. Check if this forecast comes true in a year, meanwhile watch BLUEPRINT MEDICINES CORP stock price chart and keep track of the current situation with 2L9 news and stock market news.
We've gathered opinions of 18 analysts rating 2L9 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.